Stephen Kirk, MD
Sports Medicine · St George, UTNPI 1578737979
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $358, 6.3 times the $57 reported in 2019.
Across 60 payments — averaging $25.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Therapeutics, Inc.$223
- Trice Medical, Inc.$183
- Boston Scientific$129
- Bioventus LLC$105
- Stryker$101
- Johnson & Johnson$99
- plus $673 from 17 others
What the payments were for
- Food & beverage$1,511100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Therapeutics, Inc. | 8 | $223 |
| Trice Medical, Inc. | 4 | $183 |
| Boston Scientific | 3 | $129 |
| Bioventus LLC | 6 | $105 |
| Stryker | 2 | $101 |
| Johnson & Johnson | 3 | $99 |
| Endo Pharmaceuticals Inc. | 5 | $94 |
| Anika Therapeutics, Inc. | 3 | $75 |
| Resmed Corp | 1 | $73 |
| Ferring Pharmaceuticals Inc. | 4 | $56 |
| Endo USA, Inc. | 3 | $55 |
| Avanos Medical | 3 | $54 |
| Solventum Corporation | 3 | $45 |
| Amgen | 2 | $35 |
| Vertex | 2 | $33 |
| Vericel Corporation | 1 | $28 |
| Nevro Corp. | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Fidia Pharma USA Inc. | 1 | $18 |
| Hydrocision, Inc. | 1 | $17 |
| Innovation Technologies Inc | 1 | $17 |
| Pfizer | 1 | $14 |
| SPR Therapeutics, Inc | 1 | $13 |
How this compares
$1,511 in reported general payments places this provider in the 65th percentile of 83 sports medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naproxen | 86 | $1,426 |
| Celecoxib | 107 | $1,333 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $163 |
| Meloxicam | 50 | $146 |
| Diclofenac Sodium | 11 | $142 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $72 |
| Tramadol Hcl | 15 | $66 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in St George
- Colby BarberSt George$61K
- Randy ClarkSt George$16K
- Christian MillwardSt George$315
- Chase GramesSt George$296
- Thomas RosenbergPark City$5.5M
- Charles BeckDraper$157K
- Philip DavidsonPark City$60K
- Sean DavisOgden$60K
- Trevor SheltonProvo$43K
- Gary EdwardsLehi$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.